Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [683]

CAPIRI versus irinotecan for the treatment of advanced gall bladder cancer...

Dr Anant Ramaswamy - Tata Memorial Hospital, Mumbai, India

CAPIRI versus irinotecan for the treatment of advanced gall bladder cancer patients progressing on first-line chemotherapy ( Dr Anant Ramaswamy - Tata Memorial Hospital, Mumbai, India )

DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer

Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan

DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer ( Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan )

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation...

Prof Thierry Conroy - Institute Cancer De Lorraine, Nancy, France

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer ( Prof Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )

Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based...

Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy

Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based therapy for patients with stage III colon cancer ( Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy )

The PANDA study: Combining panitumumab with FOLFOX or 5FU in elderly patients...

Dr Sara Lonardi - Istituto Oncologico Veneto, Padua, Italy

The PANDA study: Combining panitumumab with FOLFOX or 5FU in elderly patients with RAS-BRAF WT metastatic colorectal cancer ( Dr Sara Lonardi - Istituto Oncologico Veneto, Padua, Italy )

KEYNOTE-177 results: Pembrolizumab versus chemotherapy for patients with MSI-H...

Prof Thierry Andre - Sorbonne University and Saint-Antoine Hospital, Paris...

KEYNOTE-177 results: Pembrolizumab versus chemotherapy for patients with MSI-H/dMMR colorectal cancer ( Prof Thierry Andre - Sorbonne University and Saint-Antoine Hospital, Paris, France )

Highlights from ASCO 2020

Dr Bishal Gyawali - Queen's University, Kingston, Canada

Highlights from ASCO 2020 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

An oncologist's experience of managing breast cancer during the COVID-19...

Prof Alessandra Gennari - University Hospital of Novara, Piedmont, Italy

An oncologist's experience of managing breast cancer during the COVID-19 outbreak ( Prof Alessandra Gennari - University Hospital of Novara, Piedmont, Italy )

The potential of KRAS inhibitors for non-small-cell lung cancer

Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany

The potential of KRAS inhibitors for non-small-cell lung cancer ( Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany )

Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast...

Dr. Geraldo Alves - Hospital Santa Rosa, Brasil

Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast cancer ( Dr. Geraldo Alves - Hospital Santa Rosa, Brasil )

Enhancing curative resection for GI cancers; margins, nodes and recovery

Dr Robin Thambudorai- Tata Medical Center, Kolkata, India

Enhancing curative resection for GI cancers; margins, nodes and recovery ( Dr Robin Thambudorai- Tata Medical Center, Kolkata, India )

Neoadjuvant radiotherapy in rectal cancers

Prof Reena Engineer - Tata Medical Center, Kolkata, India

Neoadjuvant radiotherapy in rectal cancers ( Prof Reena Engineer - Tata Medical Center, Kolkata, India )

More from ecancer